{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihct7adpfiydmxujvzyvhm6qtrru5go73bvbvqr3gyzkxbqntstiy",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3meoh2e5jgtm2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidyx63d3tjbesom3k2f2vdjdgwkwl2fa4ostaxsfq5kj4iioes3n4"
    },
    "mimeType": "image/jpeg",
    "size": 71788
  },
  "path": "/pharmalot/2026/02/12/nih-clinical-trial-definition-research-transparency/?utm_campaign=rss",
  "publishedAt": "2026-02-12T15:59:47.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "biotechnology",
    "Clinical trials",
    "Pharmaceuticals",
    "Policy",
    "research",
    "STAT+"
  ],
  "textContent": "In a long-debated move, the NIH will no longer characterize basic experimental studies involving humans as clinical trials.",
  "title": "STAT+: NIH redefines ‘clinical trials,’ dividing researchers",
  "updatedAt": "2026-02-12T15:59:51.000Z"
}